nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—Diphenhydramine—atopic dermatitis	0.475	1	CrCtD
Reboxetine—Benzatropine—Dimenhydrinate—atopic dermatitis	0.0539	0.182	CrCrCtD
Reboxetine—Diphenylpyraline—Dimenhydrinate—atopic dermatitis	0.0381	0.128	CrCrCtD
Reboxetine—Cyclizine—Dimenhydrinate—atopic dermatitis	0.0341	0.115	CrCrCtD
Reboxetine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.028	0.0942	CrCrCtD
Reboxetine—Phenprocoumon—Diphenhydramine—atopic dermatitis	0.0266	0.0895	CrCrCtD
Reboxetine—Benzatropine—Diphenhydramine—atopic dermatitis	0.0256	0.0863	CrCrCtD
Reboxetine—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0248	0.0837	CrCrCtD
Reboxetine—Diphenylpyraline—Diphenhydramine—atopic dermatitis	0.0181	0.0609	CrCrCtD
Reboxetine—Atomoxetine—Diphenhydramine—atopic dermatitis	0.0181	0.0609	CrCrCtD
Reboxetine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0165	0.102	CbGbCtD
Reboxetine—ABCB1—Tacrolimus—atopic dermatitis	0.0164	0.101	CbGbCtD
Reboxetine—Cyclizine—Diphenhydramine—atopic dermatitis	0.0162	0.0546	CrCrCtD
Reboxetine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.0133	0.0447	CrCrCtD
Reboxetine—ABCB1—Loratadine—atopic dermatitis	0.012	0.0743	CbGbCtD
Reboxetine—CYP2D6—Loratadine—atopic dermatitis	0.0113	0.07	CbGbCtD
Reboxetine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0113	0.07	CbGbCtD
Reboxetine—ABCB1—Methylprednisolone—atopic dermatitis	0.011	0.0679	CbGbCtD
Reboxetine—CYP3A4—Tacrolimus—atopic dermatitis	0.00981	0.0608	CbGbCtD
Reboxetine—CYP3A4—Loratadine—atopic dermatitis	0.00718	0.0445	CbGbCtD
Reboxetine—ABCB1—Betamethasone—atopic dermatitis	0.00713	0.0442	CbGbCtD
Reboxetine—ABCB1—Prednisolone—atopic dermatitis	0.00703	0.0436	CbGbCtD
Reboxetine—ABCB1—Hydrocortisone—atopic dermatitis	0.00667	0.0413	CbGbCtD
Reboxetine—ABCB1—Prednisone—atopic dermatitis	0.00664	0.0411	CbGbCtD
Reboxetine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00657	0.0407	CbGbCtD
Reboxetine—CYP3A4—Triamcinolone—atopic dermatitis	0.00498	0.0308	CbGbCtD
Reboxetine—CYP3A4—Betamethasone—atopic dermatitis	0.00427	0.0265	CbGbCtD
Reboxetine—CYP3A4—Prednisolone—atopic dermatitis	0.00421	0.0261	CbGbCtD
Reboxetine—ABCB1—Dexamethasone—atopic dermatitis	0.00415	0.0257	CbGbCtD
Reboxetine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00399	0.0247	CbGbCtD
Reboxetine—CYP3A4—Prednisone—atopic dermatitis	0.00398	0.0247	CbGbCtD
Reboxetine—CYP2D6—Dexamethasone—atopic dermatitis	0.00391	0.0242	CbGbCtD
Reboxetine—CYP3A4—Dexamethasone—atopic dermatitis	0.00248	0.0154	CbGbCtD
Reboxetine—Nausea—Mometasone—atopic dermatitis	5.38e-05	0.000808	CcSEcCtD
Reboxetine—Immune system disorder—Methylprednisolone—atopic dermatitis	5.37e-05	0.000807	CcSEcCtD
Reboxetine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	5.35e-05	0.000805	CcSEcCtD
Reboxetine—Weight decreased—Prednisone—atopic dermatitis	5.32e-05	0.0008	CcSEcCtD
Reboxetine—Hypersensitivity—Tacrolimus—atopic dermatitis	5.31e-05	0.000798	CcSEcCtD
Reboxetine—Hyperglycaemia—Prednisone—atopic dermatitis	5.3e-05	0.000797	CcSEcCtD
Reboxetine—Ill-defined disorder—Prednisolone—atopic dermatitis	5.23e-05	0.000786	CcSEcCtD
Reboxetine—Visual impairment—Dexamethasone—atopic dermatitis	5.21e-05	0.000783	CcSEcCtD
Reboxetine—Visual impairment—Betamethasone—atopic dermatitis	5.21e-05	0.000783	CcSEcCtD
Reboxetine—Mental disorder—Methylprednisolone—atopic dermatitis	5.21e-05	0.000783	CcSEcCtD
Reboxetine—Malnutrition—Methylprednisolone—atopic dermatitis	5.17e-05	0.000778	CcSEcCtD
Reboxetine—Asthenia—Tacrolimus—atopic dermatitis	5.17e-05	0.000777	CcSEcCtD
Reboxetine—Ill-defined disorder—Hydrocortisone—atopic dermatitis	5.11e-05	0.000768	CcSEcCtD
Reboxetine—Malaise—Prednisolone—atopic dermatitis	5.08e-05	0.000764	CcSEcCtD
Reboxetine—Dysgeusia—Triamcinolone—atopic dermatitis	5.08e-05	0.000763	CcSEcCtD
Reboxetine—Vertigo—Prednisolone—atopic dermatitis	5.06e-05	0.000762	CcSEcCtD
Reboxetine—Syncope—Prednisolone—atopic dermatitis	5.06e-05	0.00076	CcSEcCtD
Reboxetine—Eye disorder—Betamethasone—atopic dermatitis	5.05e-05	0.000759	CcSEcCtD
Reboxetine—Eye disorder—Dexamethasone—atopic dermatitis	5.05e-05	0.000759	CcSEcCtD
Reboxetine—Malaise—Hydrocortisone—atopic dermatitis	4.96e-05	0.000747	CcSEcCtD
Reboxetine—Loss of consciousness—Prednisolone—atopic dermatitis	4.95e-05	0.000745	CcSEcCtD
Reboxetine—Vertigo—Hydrocortisone—atopic dermatitis	4.95e-05	0.000744	CcSEcCtD
Reboxetine—Syncope—Hydrocortisone—atopic dermatitis	4.94e-05	0.000742	CcSEcCtD
Reboxetine—Diarrhoea—Tacrolimus—atopic dermatitis	4.93e-05	0.000741	CcSEcCtD
Reboxetine—Angiopathy—Betamethasone—atopic dermatitis	4.9e-05	0.000737	CcSEcCtD
Reboxetine—Angiopathy—Dexamethasone—atopic dermatitis	4.9e-05	0.000737	CcSEcCtD
Reboxetine—Hypertension—Prednisolone—atopic dermatitis	4.87e-05	0.000732	CcSEcCtD
Reboxetine—Loss of consciousness—Hydrocortisone—atopic dermatitis	4.84e-05	0.000728	CcSEcCtD
Reboxetine—Ill-defined disorder—Triamcinolone—atopic dermatitis	4.81e-05	0.000723	CcSEcCtD
Reboxetine—Ill-defined disorder—Methylprednisolone—atopic dermatitis	4.8e-05	0.000722	CcSEcCtD
Reboxetine—Bradycardia—Prednisone—atopic dermatitis	4.79e-05	0.00072	CcSEcCtD
Reboxetine—Dizziness—Tacrolimus—atopic dermatitis	4.76e-05	0.000716	CcSEcCtD
Reboxetine—Hypertension—Hydrocortisone—atopic dermatitis	4.75e-05	0.000715	CcSEcCtD
Reboxetine—Discomfort—Prednisolone—atopic dermatitis	4.74e-05	0.000713	CcSEcCtD
Reboxetine—Hallucination—Prednisone—atopic dermatitis	4.68e-05	0.000704	CcSEcCtD
Reboxetine—Malaise—Triamcinolone—atopic dermatitis	4.67e-05	0.000703	CcSEcCtD
Reboxetine—Anxiety—Hydrocortisone—atopic dermatitis	4.67e-05	0.000702	CcSEcCtD
Reboxetine—Malaise—Methylprednisolone—atopic dermatitis	4.66e-05	0.000701	CcSEcCtD
Reboxetine—Vertigo—Triamcinolone—atopic dermatitis	4.66e-05	0.0007	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.65e-05	0.0007	CcSEcCtD
Reboxetine—Syncope—Triamcinolone—atopic dermatitis	4.65e-05	0.000699	CcSEcCtD
Reboxetine—Vertigo—Methylprednisolone—atopic dermatitis	4.65e-05	0.000699	CcSEcCtD
Reboxetine—Syncope—Methylprednisolone—atopic dermatitis	4.64e-05	0.000698	CcSEcCtD
Reboxetine—Discomfort—Hydrocortisone—atopic dermatitis	4.63e-05	0.000696	CcSEcCtD
Reboxetine—Connective tissue disorder—Prednisone—atopic dermatitis	4.62e-05	0.000695	CcSEcCtD
Reboxetine—Vomiting—Tacrolimus—atopic dermatitis	4.58e-05	0.000689	CcSEcCtD
Reboxetine—Loss of consciousness—Triamcinolone—atopic dermatitis	4.56e-05	0.000685	CcSEcCtD
Reboxetine—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.55e-05	0.000684	CcSEcCtD
Reboxetine—Rash—Tacrolimus—atopic dermatitis	4.54e-05	0.000683	CcSEcCtD
Reboxetine—Dermatitis—Tacrolimus—atopic dermatitis	4.54e-05	0.000682	CcSEcCtD
Reboxetine—Shock—Prednisolone—atopic dermatitis	4.53e-05	0.000681	CcSEcCtD
Reboxetine—Headache—Tacrolimus—atopic dermatitis	4.51e-05	0.000679	CcSEcCtD
Reboxetine—Tachycardia—Prednisolone—atopic dermatitis	4.49e-05	0.000675	CcSEcCtD
Reboxetine—Hypertension—Triamcinolone—atopic dermatitis	4.48e-05	0.000673	CcSEcCtD
Reboxetine—Hypertension—Methylprednisolone—atopic dermatitis	4.47e-05	0.000672	CcSEcCtD
Reboxetine—Infection—Hydrocortisone—atopic dermatitis	4.46e-05	0.000671	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisolone—atopic dermatitis	4.45e-05	0.000669	CcSEcCtD
Reboxetine—Shock—Hydrocortisone—atopic dermatitis	4.42e-05	0.000665	CcSEcCtD
Reboxetine—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.41e-05	0.000663	CcSEcCtD
Reboxetine—Eye disorder—Prednisone—atopic dermatitis	4.4e-05	0.000661	CcSEcCtD
Reboxetine—Anxiety—Methylprednisolone—atopic dermatitis	4.39e-05	0.00066	CcSEcCtD
Reboxetine—Tachycardia—Hydrocortisone—atopic dermatitis	4.39e-05	0.000659	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.37e-05	0.000658	CcSEcCtD
Reboxetine—Skin disorder—Hydrocortisone—atopic dermatitis	4.36e-05	0.000656	CcSEcCtD
Reboxetine—Ill-defined disorder—Dexamethasone—atopic dermatitis	4.36e-05	0.000656	CcSEcCtD
Reboxetine—Ill-defined disorder—Betamethasone—atopic dermatitis	4.36e-05	0.000656	CcSEcCtD
Reboxetine—Discomfort—Triamcinolone—atopic dermatitis	4.36e-05	0.000656	CcSEcCtD
Reboxetine—Discomfort—Methylprednisolone—atopic dermatitis	4.35e-05	0.000654	CcSEcCtD
Reboxetine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.34e-05	0.000653	CcSEcCtD
Reboxetine—Dry mouth—Triamcinolone—atopic dermatitis	4.32e-05	0.000649	CcSEcCtD
Reboxetine—Anorexia—Hydrocortisone—atopic dermatitis	4.28e-05	0.000644	CcSEcCtD
Reboxetine—Nausea—Tacrolimus—atopic dermatitis	4.28e-05	0.000643	CcSEcCtD
Reboxetine—Angiopathy—Prednisone—atopic dermatitis	4.27e-05	0.000642	CcSEcCtD
Reboxetine—Confusional state—Methylprednisolone—atopic dermatitis	4.26e-05	0.00064	CcSEcCtD
Reboxetine—Immune system disorder—Prednisone—atopic dermatitis	4.25e-05	0.000639	CcSEcCtD
Reboxetine—Malaise—Dexamethasone—atopic dermatitis	4.24e-05	0.000638	CcSEcCtD
Reboxetine—Malaise—Betamethasone—atopic dermatitis	4.24e-05	0.000638	CcSEcCtD
Reboxetine—Vertigo—Dexamethasone—atopic dermatitis	4.23e-05	0.000635	CcSEcCtD
Reboxetine—Vertigo—Betamethasone—atopic dermatitis	4.23e-05	0.000635	CcSEcCtD
Reboxetine—Syncope—Dexamethasone—atopic dermatitis	4.22e-05	0.000634	CcSEcCtD
Reboxetine—Syncope—Betamethasone—atopic dermatitis	4.22e-05	0.000634	CcSEcCtD
Reboxetine—Infection—Triamcinolone—atopic dermatitis	4.2e-05	0.000632	CcSEcCtD
Reboxetine—Hypotension—Hydrocortisone—atopic dermatitis	4.2e-05	0.000631	CcSEcCtD
Reboxetine—Infection—Methylprednisolone—atopic dermatitis	4.19e-05	0.000631	CcSEcCtD
Reboxetine—Shock—Triamcinolone—atopic dermatitis	4.16e-05	0.000626	CcSEcCtD
Reboxetine—Insomnia—Prednisolone—atopic dermatitis	4.16e-05	0.000626	CcSEcCtD
Reboxetine—Shock—Methylprednisolone—atopic dermatitis	4.15e-05	0.000625	CcSEcCtD
Reboxetine—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.14e-05	0.000623	CcSEcCtD
Reboxetine—Loss of consciousness—Dexamethasone—atopic dermatitis	4.13e-05	0.000622	CcSEcCtD
Reboxetine—Loss of consciousness—Betamethasone—atopic dermatitis	4.13e-05	0.000622	CcSEcCtD
Reboxetine—Paraesthesia—Prednisolone—atopic dermatitis	4.13e-05	0.000621	CcSEcCtD
Reboxetine—Tachycardia—Triamcinolone—atopic dermatitis	4.13e-05	0.000621	CcSEcCtD
Reboxetine—Mental disorder—Prednisone—atopic dermatitis	4.12e-05	0.00062	CcSEcCtD
Reboxetine—Tachycardia—Methylprednisolone—atopic dermatitis	4.12e-05	0.00062	CcSEcCtD
Reboxetine—Skin disorder—Methylprednisolone—atopic dermatitis	4.1e-05	0.000617	CcSEcCtD
Reboxetine—Malnutrition—Prednisone—atopic dermatitis	4.1e-05	0.000616	CcSEcCtD
Reboxetine—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.09e-05	0.000615	CcSEcCtD
Reboxetine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.08e-05	0.000614	CcSEcCtD
Reboxetine—Insomnia—Hydrocortisone—atopic dermatitis	4.06e-05	0.000611	CcSEcCtD
Reboxetine—Hypertension—Betamethasone—atopic dermatitis	4.06e-05	0.000611	CcSEcCtD
Reboxetine—Hypertension—Dexamethasone—atopic dermatitis	4.06e-05	0.000611	CcSEcCtD
Reboxetine—Paraesthesia—Hydrocortisone—atopic dermatitis	4.03e-05	0.000607	CcSEcCtD
Reboxetine—Anxiety—Betamethasone—atopic dermatitis	3.99e-05	0.0006	CcSEcCtD
Reboxetine—Anxiety—Dexamethasone—atopic dermatitis	3.99e-05	0.0006	CcSEcCtD
Reboxetine—Discomfort—Betamethasone—atopic dermatitis	3.96e-05	0.000595	CcSEcCtD
Reboxetine—Discomfort—Dexamethasone—atopic dermatitis	3.96e-05	0.000595	CcSEcCtD
Reboxetine—Dyspepsia—Hydrocortisone—atopic dermatitis	3.96e-05	0.000595	CcSEcCtD
Reboxetine—Hypotension—Methylprednisolone—atopic dermatitis	3.94e-05	0.000593	CcSEcCtD
Reboxetine—Decreased appetite—Hydrocortisone—atopic dermatitis	3.91e-05	0.000587	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	3.88e-05	0.000583	CcSEcCtD
Reboxetine—Insomnia—Triamcinolone—atopic dermatitis	3.83e-05	0.000575	CcSEcCtD
Reboxetine—Insomnia—Methylprednisolone—atopic dermatitis	3.82e-05	0.000574	CcSEcCtD
Reboxetine—Infection—Dexamethasone—atopic dermatitis	3.81e-05	0.000573	CcSEcCtD
Reboxetine—Infection—Betamethasone—atopic dermatitis	3.81e-05	0.000573	CcSEcCtD
Reboxetine—Ill-defined disorder—Prednisone—atopic dermatitis	3.8e-05	0.000572	CcSEcCtD
Reboxetine—Paraesthesia—Triamcinolone—atopic dermatitis	3.8e-05	0.000571	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisolone—atopic dermatitis	3.79e-05	0.00057	CcSEcCtD
Reboxetine—Paraesthesia—Methylprednisolone—atopic dermatitis	3.79e-05	0.00057	CcSEcCtD
Reboxetine—Anaemia—Prednisone—atopic dermatitis	3.79e-05	0.000569	CcSEcCtD
Reboxetine—Shock—Betamethasone—atopic dermatitis	3.78e-05	0.000568	CcSEcCtD
Reboxetine—Shock—Dexamethasone—atopic dermatitis	3.78e-05	0.000568	CcSEcCtD
Reboxetine—Dyspnoea—Triamcinolone—atopic dermatitis	3.77e-05	0.000567	CcSEcCtD
Reboxetine—Nervous system disorder—Betamethasone—atopic dermatitis	3.76e-05	0.000566	CcSEcCtD
Reboxetine—Nervous system disorder—Dexamethasone—atopic dermatitis	3.76e-05	0.000566	CcSEcCtD
Reboxetine—Agitation—Prednisone—atopic dermatitis	3.76e-05	0.000566	CcSEcCtD
Reboxetine—Tachycardia—Betamethasone—atopic dermatitis	3.75e-05	0.000563	CcSEcCtD
Reboxetine—Tachycardia—Dexamethasone—atopic dermatitis	3.75e-05	0.000563	CcSEcCtD
Reboxetine—Dyspepsia—Triamcinolone—atopic dermatitis	3.72e-05	0.00056	CcSEcCtD
Reboxetine—Dyspepsia—Methylprednisolone—atopic dermatitis	3.72e-05	0.000559	CcSEcCtD
Reboxetine—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.71e-05	0.000558	CcSEcCtD
Reboxetine—Hyperhidrosis—Betamethasone—atopic dermatitis	3.71e-05	0.000558	CcSEcCtD
Reboxetine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.7e-05	0.000557	CcSEcCtD
Reboxetine—Malaise—Prednisone—atopic dermatitis	3.69e-05	0.000555	CcSEcCtD
Reboxetine—Vertigo—Prednisone—atopic dermatitis	3.68e-05	0.000553	CcSEcCtD
Reboxetine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.67e-05	0.000552	CcSEcCtD
Reboxetine—Syncope—Prednisone—atopic dermatitis	3.67e-05	0.000552	CcSEcCtD
Reboxetine—Anorexia—Dexamethasone—atopic dermatitis	3.66e-05	0.00055	CcSEcCtD
Reboxetine—Anorexia—Betamethasone—atopic dermatitis	3.66e-05	0.00055	CcSEcCtD
Reboxetine—Urticaria—Prednisolone—atopic dermatitis	3.65e-05	0.00055	CcSEcCtD
Reboxetine—Loss of consciousness—Prednisone—atopic dermatitis	3.6e-05	0.000541	CcSEcCtD
Reboxetine—Hypotension—Dexamethasone—atopic dermatitis	3.59e-05	0.000539	CcSEcCtD
Reboxetine—Hypotension—Betamethasone—atopic dermatitis	3.59e-05	0.000539	CcSEcCtD
Reboxetine—Urticaria—Hydrocortisone—atopic dermatitis	3.57e-05	0.000537	CcSEcCtD
Reboxetine—Body temperature increased—Hydrocortisone—atopic dermatitis	3.55e-05	0.000534	CcSEcCtD
Reboxetine—Abdominal pain—Hydrocortisone—atopic dermatitis	3.55e-05	0.000534	CcSEcCtD
Reboxetine—Hypertension—Prednisone—atopic dermatitis	3.54e-05	0.000532	CcSEcCtD
Reboxetine—Feeling abnormal—Triamcinolone—atopic dermatitis	3.49e-05	0.000524	CcSEcCtD
Reboxetine—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.48e-05	0.000523	CcSEcCtD
Reboxetine—Anxiety—Prednisone—atopic dermatitis	3.48e-05	0.000523	CcSEcCtD
Reboxetine—Insomnia—Betamethasone—atopic dermatitis	3.47e-05	0.000522	CcSEcCtD
Reboxetine—Insomnia—Dexamethasone—atopic dermatitis	3.47e-05	0.000522	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.46e-05	0.000521	CcSEcCtD
Reboxetine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.45e-05	0.000519	CcSEcCtD
Reboxetine—Paraesthesia—Dexamethasone—atopic dermatitis	3.45e-05	0.000518	CcSEcCtD
Reboxetine—Paraesthesia—Betamethasone—atopic dermatitis	3.45e-05	0.000518	CcSEcCtD
Reboxetine—Discomfort—Prednisone—atopic dermatitis	3.45e-05	0.000518	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisolone—atopic dermatitis	3.39e-05	0.00051	CcSEcCtD
Reboxetine—Dyspepsia—Dexamethasone—atopic dermatitis	3.38e-05	0.000508	CcSEcCtD
Reboxetine—Dyspepsia—Betamethasone—atopic dermatitis	3.38e-05	0.000508	CcSEcCtD
Reboxetine—Urticaria—Triamcinolone—atopic dermatitis	3.36e-05	0.000505	CcSEcCtD
Reboxetine—Urticaria—Methylprednisolone—atopic dermatitis	3.35e-05	0.000504	CcSEcCtD
Reboxetine—Body temperature increased—Triamcinolone—atopic dermatitis	3.34e-05	0.000503	CcSEcCtD
Reboxetine—Abdominal pain—Methylprednisolone—atopic dermatitis	3.34e-05	0.000502	CcSEcCtD
Reboxetine—Decreased appetite—Dexamethasone—atopic dermatitis	3.34e-05	0.000502	CcSEcCtD
Reboxetine—Decreased appetite—Betamethasone—atopic dermatitis	3.34e-05	0.000502	CcSEcCtD
Reboxetine—Infection—Prednisone—atopic dermatitis	3.32e-05	0.000499	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.31e-05	0.000498	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.31e-05	0.000498	CcSEcCtD
Reboxetine—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.31e-05	0.000498	CcSEcCtD
Reboxetine—Shock—Prednisone—atopic dermatitis	3.29e-05	0.000495	CcSEcCtD
Reboxetine—Nervous system disorder—Prednisone—atopic dermatitis	3.28e-05	0.000493	CcSEcCtD
Reboxetine—Tachycardia—Prednisone—atopic dermatitis	3.26e-05	0.000491	CcSEcCtD
Reboxetine—Skin disorder—Prednisone—atopic dermatitis	3.25e-05	0.000488	CcSEcCtD
Reboxetine—Hyperhidrosis—Prednisone—atopic dermatitis	3.23e-05	0.000486	CcSEcCtD
Reboxetine—Asthenia—Hydrocortisone—atopic dermatitis	3.22e-05	0.000485	CcSEcCtD
Reboxetine—Anorexia—Prednisone—atopic dermatitis	3.19e-05	0.000479	CcSEcCtD
Reboxetine—Feeling abnormal—Betamethasone—atopic dermatitis	3.16e-05	0.000476	CcSEcCtD
Reboxetine—Feeling abnormal—Dexamethasone—atopic dermatitis	3.16e-05	0.000476	CcSEcCtD
Reboxetine—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.14e-05	0.000472	CcSEcCtD
Reboxetine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.14e-05	0.000472	CcSEcCtD
Reboxetine—Hypersensitivity—Triamcinolone—atopic dermatitis	3.12e-05	0.000469	CcSEcCtD
Reboxetine—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.11e-05	0.000468	CcSEcCtD
Reboxetine—Diarrhoea—Hydrocortisone—atopic dermatitis	3.07e-05	0.000462	CcSEcCtD
Reboxetine—Urticaria—Dexamethasone—atopic dermatitis	3.05e-05	0.000459	CcSEcCtD
Reboxetine—Urticaria—Betamethasone—atopic dermatitis	3.05e-05	0.000459	CcSEcCtD
Reboxetine—Dizziness—Prednisolone—atopic dermatitis	3.04e-05	0.000457	CcSEcCtD
Reboxetine—Asthenia—Triamcinolone—atopic dermatitis	3.04e-05	0.000456	CcSEcCtD
Reboxetine—Body temperature increased—Dexamethasone—atopic dermatitis	3.03e-05	0.000456	CcSEcCtD
Reboxetine—Abdominal pain—Betamethasone—atopic dermatitis	3.03e-05	0.000456	CcSEcCtD
Reboxetine—Abdominal pain—Dexamethasone—atopic dermatitis	3.03e-05	0.000456	CcSEcCtD
Reboxetine—Body temperature increased—Betamethasone—atopic dermatitis	3.03e-05	0.000456	CcSEcCtD
Reboxetine—Asthenia—Methylprednisolone—atopic dermatitis	3.03e-05	0.000455	CcSEcCtD
Reboxetine—Insomnia—Prednisone—atopic dermatitis	3.02e-05	0.000455	CcSEcCtD
Reboxetine—Paraesthesia—Prednisone—atopic dermatitis	3e-05	0.000451	CcSEcCtD
Reboxetine—Dizziness—Hydrocortisone—atopic dermatitis	2.97e-05	0.000447	CcSEcCtD
Reboxetine—Dyspepsia—Prednisone—atopic dermatitis	2.94e-05	0.000443	CcSEcCtD
Reboxetine—Decreased appetite—Prednisone—atopic dermatitis	2.91e-05	0.000437	CcSEcCtD
Reboxetine—Rash—Prednisolone—atopic dermatitis	2.9e-05	0.000436	CcSEcCtD
Reboxetine—Dermatitis—Prednisolone—atopic dermatitis	2.9e-05	0.000436	CcSEcCtD
Reboxetine—Diarrhoea—Methylprednisolone—atopic dermatitis	2.89e-05	0.000434	CcSEcCtD
Reboxetine—Headache—Prednisolone—atopic dermatitis	2.88e-05	0.000433	CcSEcCtD
Reboxetine—Constipation—Prednisone—atopic dermatitis	2.86e-05	0.00043	CcSEcCtD
Reboxetine—Vomiting—Hydrocortisone—atopic dermatitis	2.86e-05	0.00043	CcSEcCtD
Reboxetine—Rash—Hydrocortisone—atopic dermatitis	2.83e-05	0.000426	CcSEcCtD
Reboxetine—Dermatitis—Hydrocortisone—atopic dermatitis	2.83e-05	0.000426	CcSEcCtD
Reboxetine—Headache—Hydrocortisone—atopic dermatitis	2.81e-05	0.000423	CcSEcCtD
Reboxetine—Dizziness—Triamcinolone—atopic dermatitis	2.8e-05	0.000421	CcSEcCtD
Reboxetine—Dizziness—Methylprednisolone—atopic dermatitis	2.79e-05	0.00042	CcSEcCtD
Reboxetine—Feeling abnormal—Prednisone—atopic dermatitis	2.75e-05	0.000414	CcSEcCtD
Reboxetine—Asthenia—Betamethasone—atopic dermatitis	2.75e-05	0.000414	CcSEcCtD
Reboxetine—Asthenia—Dexamethasone—atopic dermatitis	2.75e-05	0.000414	CcSEcCtD
Reboxetine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.73e-05	0.000411	CcSEcCtD
Reboxetine—Nausea—Prednisolone—atopic dermatitis	2.73e-05	0.000411	CcSEcCtD
Reboxetine—Vomiting—Triamcinolone—atopic dermatitis	2.69e-05	0.000405	CcSEcCtD
Reboxetine—Vomiting—Methylprednisolone—atopic dermatitis	2.68e-05	0.000404	CcSEcCtD
Reboxetine—Nausea—Hydrocortisone—atopic dermatitis	2.67e-05	0.000401	CcSEcCtD
Reboxetine—Rash—Triamcinolone—atopic dermatitis	2.67e-05	0.000401	CcSEcCtD
Reboxetine—Dermatitis—Triamcinolone—atopic dermatitis	2.67e-05	0.000401	CcSEcCtD
Reboxetine—Rash—Methylprednisolone—atopic dermatitis	2.66e-05	0.0004	CcSEcCtD
Reboxetine—Dermatitis—Methylprednisolone—atopic dermatitis	2.66e-05	0.0004	CcSEcCtD
Reboxetine—Urticaria—Prednisone—atopic dermatitis	2.66e-05	0.000399	CcSEcCtD
Reboxetine—Headache—Triamcinolone—atopic dermatitis	2.65e-05	0.000399	CcSEcCtD
Reboxetine—Headache—Methylprednisolone—atopic dermatitis	2.64e-05	0.000398	CcSEcCtD
Reboxetine—Body temperature increased—Prednisone—atopic dermatitis	2.64e-05	0.000397	CcSEcCtD
Reboxetine—Abdominal pain—Prednisone—atopic dermatitis	2.64e-05	0.000397	CcSEcCtD
Reboxetine—Diarrhoea—Betamethasone—atopic dermatitis	2.63e-05	0.000395	CcSEcCtD
Reboxetine—Diarrhoea—Dexamethasone—atopic dermatitis	2.63e-05	0.000395	CcSEcCtD
Reboxetine—Dizziness—Betamethasone—atopic dermatitis	2.54e-05	0.000382	CcSEcCtD
Reboxetine—Dizziness—Dexamethasone—atopic dermatitis	2.54e-05	0.000382	CcSEcCtD
Reboxetine—Nausea—Triamcinolone—atopic dermatitis	2.51e-05	0.000378	CcSEcCtD
Reboxetine—Nausea—Methylprednisolone—atopic dermatitis	2.51e-05	0.000377	CcSEcCtD
Reboxetine—Hypersensitivity—Prednisone—atopic dermatitis	2.46e-05	0.00037	CcSEcCtD
Reboxetine—Vomiting—Betamethasone—atopic dermatitis	2.44e-05	0.000367	CcSEcCtD
Reboxetine—Vomiting—Dexamethasone—atopic dermatitis	2.44e-05	0.000367	CcSEcCtD
Reboxetine—Rash—Dexamethasone—atopic dermatitis	2.42e-05	0.000364	CcSEcCtD
Reboxetine—Rash—Betamethasone—atopic dermatitis	2.42e-05	0.000364	CcSEcCtD
Reboxetine—Dermatitis—Dexamethasone—atopic dermatitis	2.42e-05	0.000364	CcSEcCtD
Reboxetine—Dermatitis—Betamethasone—atopic dermatitis	2.42e-05	0.000364	CcSEcCtD
Reboxetine—Headache—Dexamethasone—atopic dermatitis	2.4e-05	0.000362	CcSEcCtD
Reboxetine—Headache—Betamethasone—atopic dermatitis	2.4e-05	0.000362	CcSEcCtD
Reboxetine—Asthenia—Prednisone—atopic dermatitis	2.4e-05	0.000361	CcSEcCtD
Reboxetine—Diarrhoea—Prednisone—atopic dermatitis	2.29e-05	0.000344	CcSEcCtD
Reboxetine—Nausea—Dexamethasone—atopic dermatitis	2.28e-05	0.000343	CcSEcCtD
Reboxetine—Nausea—Betamethasone—atopic dermatitis	2.28e-05	0.000343	CcSEcCtD
Reboxetine—Dizziness—Prednisone—atopic dermatitis	2.21e-05	0.000332	CcSEcCtD
Reboxetine—Vomiting—Prednisone—atopic dermatitis	2.13e-05	0.00032	CcSEcCtD
Reboxetine—Rash—Prednisone—atopic dermatitis	2.11e-05	0.000317	CcSEcCtD
Reboxetine—Dermatitis—Prednisone—atopic dermatitis	2.11e-05	0.000317	CcSEcCtD
Reboxetine—Headache—Prednisone—atopic dermatitis	2.09e-05	0.000315	CcSEcCtD
Reboxetine—Nausea—Prednisone—atopic dermatitis	1.99e-05	0.000299	CcSEcCtD
